Allurion Technologies (NYSE:ALUR) Issues Earnings Results, Misses Expectations By $2.25 EPS

Allurion Technologies (NYSE:ALUR) announced its quarterly earnings data on Wednesday. The company reported ($7.00) earnings per share for the quarter, missing the consensus estimate of ($4.75) by ($2.25), Zacks reports.

Allurion Technologies Trading Down 11.0 %

ALUR stock opened at $2.77 on Wednesday. The firm has a 50-day moving average price of $4.01 and a 200-day moving average price of $9.93. Allurion Technologies has a 12 month low of $2.15 and a 12 month high of $98.75. The stock has a market capitalization of $13.27 million, a P/E ratio of -0.23 and a beta of -0.59.

Wall Street Analyst Weigh In

Several brokerages have recently commented on ALUR. Chardan Capital restated a “neutral” rating and issued a $2.50 target price on shares of Allurion Technologies in a research report on Friday, March 21st. Roth Mkm restated a “buy” rating and set a $16.00 price objective on shares of Allurion Technologies in a research report on Friday, March 21st.

Allurion Technologies Company Profile

Allurion Technologies Inc focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform, the Allurion Program, features swallowable and procedure-less intragastric balloon for weight loss (the Allurion Balloon), as well as offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite.